Select Page


Latest Members

Medicon Valley Alliance is continually adding new life science companies and organisations as members.

These companies and organisations have decided to join forces and strengthen their ties within the region, thereby anhancing their visibility with national and international companies looking at life science in Medicon Valley.

Below is a list of the companies that have most recently joined the Medicon Valley Alliance!

Take a look and see if one of them is your new business partner. If you wish to view a directory of all companies and organisations in Medicon Valley – click here!


RAMCON was established in 1988 and is today a modern company with more than 80 employees in sales, support, and service. We focus on these three core areas, and we target the Industrial, Medical, Chemical and Life Science market in the Nordic countries. RAMCON currently have 4 offices placed in Birkerød, Vejle, Gothenburg and Stockholm.

RAMCON is a focused distributor with a robust organization with a high level of professionalism. The company is ISO 9001:2015 certified and consist of competent and well-educated employees. Our strength is to know our customers’ needs as well as a vast knowledge of the Industrial, Medical, Chemical and Life Science market. RAMCON constantly strives to be an organization characterized by a positive social atmosphere. We value integrity and respect for colleagues, customers, and partners highly. We invest in people as the primary marketing resource and offer a high level of service and support to our customers. It is the company’s strategy to build good and lasting customer relations.


Organon is a global healthcare company formed to focus on improving the health of women throughout their lives. Organon offers more than 60 medicines and products in women’s health in addition to a growing biosimilars business and a large franchise of established medicines across a range of therapeutic areas. Organon’s existing products produce strong cash flows that support investments in innovation and future growth opportunities in women’s health and biosimilars. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets.

Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 10,000 employees with headquarters located in Jersey City, New Jersey.

Carbiotix AB

Carbiotix AB is an award-winning biotechnology company pioneering microbiome healthcare through a portfolio of prebiotic modulators (CarbiAXOS) and diagnostic testing services (LinkGut service). We are a company that is focused on continually innovating and improving our prebiotic products, how we deliver them to market, and how we verify their efficacy. In doing so, we are dedicated to delivering as much value as possible to our customers, partners, and other stakeholders. Carbiotix’s mission is to increase the consumption of prebiotics in people’s diets by:

  • Manufacturing the lowest cost and most effective prebiotics possible.
  • Selling our portfolio of prebiotics through as many forms and channels as possible.
  • Providing the lowest cost consumer microbiome test possible.


Bionamic is a Lund based software company helping antibody focused biopharma companies accelerate their discovery and development of life saving drugs. The Bionamic SaaS solution is designed for a single purpose: To bring all relevant sequence, assay and meta data together in one place to enable faster and more powerful analysis and visualizations with full traceability.

In the field of antibody research, data is the engine that drives discovery and development. That makes it crucial to be able to use your data in ways that match the way you actually work. Bionamic provides unparalleled access and control over the vital data generated by your research.

By consolidating all of your data within a single software solution, we make it easy to find the information you need, when you need it. That improved access saves valuable time and allows your team to visualize key data to draw deeper insights. Bionamic’s easy-to-use tools work in synergy with your existing lab management software to streamline antibody research and help you develop therapies that will change our world.

GenScript ProBio

GenScript ProBio – Biologics CDMO

GenScript ProBio, a subsidiary of GenScript Biotech Corporation, offers end-to-end CDMO services from drug discovery to commercialization with proactive strategies, professional solutions and efficient processes in CGT, vaccine, biologics discovery and antibody protein drug, aiming to accelerate drug development for customers. GenScript ProBio has established companies in the United States, the Netherlands, South Korea, and China (Hong Kong, Shanghai, and Nanjing) and other regions to serve global customers, and has helped customers in the United States, Europe, Asia Pacific and other regions obtain more than 50 IND approvals since October 2017.

GenScript ProBio’s total CGT solution covers CMC of plasmid and virus for IND filing as well as clinical manufacturing and commercial manufacturing. GenScript ProBio’s innovative solutions for biologics discovery and development include therapeutic antibody discovery, antibody engineering and antibody characterization. In the biologics CDMO service, GenScript ProBio has built a DNA to GMP material platform, including stable cell line development, host cell commercial license, process development, analytical development to clinical and commercial manufacturing, and offer fed-batch and perfusion processes to meet the growing needs for antibody and protein drugs. GenScript ProBio has established GMP capacity that meets regulatory requirements of the US Food and Drug Administration (FDA), European Medicines Agency (EMA) and National Medical Products Administration (NMPA).

Toward the mission of “Innovation through Collaboration”, GenScript ProBio is committed to helping customers shorten the timeline for the development of biological drugs from discovery to commercialization, significantly lowering R&D costs and shaping a healthier future.


Clario is a leading healthcare research and technology company that generates the richest clinical evidence in the industry for our pharmaceutical, biotech and medical device partners. Across decentralized, hybrid and site-based trials, our deep scientific expertise, global scale and the broadest endpoint technology platform in the industry allows our partners to transform lives. Clario has the only technology platform that combines eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. Clario’s global team of science, technology and operational experts have helped deliver over 24,000 trials and contributed to over 500 FDA and EMEA new drug approvals involving more than five million patients in 120 countries. Our innovation has been transforming clinical trials for 50 years.  For more information, visit or follow us on LinkedIn and Twitter.


We are in the business of building authentic, long-term relationships with our clients, who are some of the world’s most successful and innovative investors, entrepreneurs and disruptors in the life sciences, private equity, real estate, technology and financial industries, and where they converge. Our immersive understanding of these industries – combined with our expertise across high-stakes litigation and dispute resolution, world-class regulatory compliance and advisory services, and complex transactions – sets us apart. Our global life sciences practice serves both innovator and investors clients and works collaboratively to improve patients’ lives. We advise companies from pure startups to commercial stage biopharmaceuticals, as well as the investors, banks and other entities who support those companies. Our unique combination of deep experience serving both the innovators and investors in a rapidly changing, technology-driven economy sets us apart. To learn more, visit, us at and follow us on Twitter, LinkedIn, and Instagram.


AIS Sprog

AIS Sprog was founded in 1967 and is the oldest privately owned language school in Denmark.

Our Mission is to provide language instruction and cultural training to private and public companies throughout Denmark and the Øresund region, as well as offering linguistic services in all languages.

In the long term, the Vision is to continually develop new courses, services and ways of teaching that will enhance understanding between people who have different linguistic and cultural backgrounds and help our course participants improve their professional and personal skills.

From the very first contact about the planning of a language course or a cultural training session, we do our utmost to understand the needs and requirements of potential course participants. Thus, during the initial needs-analysis phase, we listen carefully to you to understand your expectations. In most cases, we arrange a free pre-course meeting in person or online to get to know your wishes for the training to tailor its content to your background, level, communication situations, personality and learning goals.

Our Values are to be accommodating and respectful in all possible ways, to provide high-quality courses and communicate and cooperate effectively with you throughout the course.

We would be pleased to hear from you.

Collaborative Drug Discovery

Collaborative Drug Discovery (CDD) provides an intuitive software suite extensively used by biologists and chemists working in academic, biotechnology and pharmaceutical settings. Their flagship product, CDD Vault, enables researchers to intuitively organize and analyze both biological and chemical data, and to collaborate with partners through a straightforward web interface.

Learn more at

ABclonal Technology

Who we are:
ABclonal Technology is an innovative growth company that provides high-quality catalog antibodies as well as antibody discovery/nanabody discovery/antibody humanization service. ABclonal has set up R&D centers in China and the US to develop and manufacture products with the aim of providing cost-effective research tools and high-quality services to biological scientists, biochemists, as well as clinical research laboratories, IVD companies and pharmaceutical companies.

Unique Antibody Technology Platforms:

The SMab platform is a single B-cell based monoclonal antibody discovery platform complete with a protocol for single B-cell sorting, culture, and antibody gene cloning. This platform cultures B lymphocytes for several weeks, obtained by FACS sorting, by stimulating B cells, with a proprietary culture medium formula, to proliferate in vitro and secrete a sufficient amount of antibody IgG for primary screening.

The SMabTM platform has successfully screened rabbit, alpaca, pig, humanized mouse and even human monoclonal antibodies. The SMabTM platform has completely broken the technical monopoly rabbit hybridoma cell technology held on rabbit monoclonal antibody discovery, successfully developing more than 800 rabbit monoclonal antibodies for customers at home and abroad, including:

  • Anti-idiotype antibody
  • Antibodies that target post-translational modification (phosphorylation, palmitation, etc.) sites
  • Small molecule organic compound (vitamin D, sterols, etc.) antibodies
  • Single nucleotide antibodies
  • Antibodies for pathological diagnosis
  • Antibody pairs and ELISA kit
  • Therapeutic rabbit monoclonal antibodies